# Moderna-Merck combination succeeds in late-stage skin cancer trial

https://mins.news/en/item/26142

- CNN, 2026-08-19 12:30 UTC
- Health
- Original: https://www.cnn.com/2026/08/19/health/moderna-merck-mrna-melanoma-vaccine?Date=20260819&Profile=CNN

> Moderna and Merck said a combination of Moderna’s mRNA vaccine and Merck’s Keytruda immunotherapy succeeded in a late-stage skin cancer trial, sending Moderna shares up 60% in premarket trading.

## Related coverage

- [Moderna and Merck unveil mRNA cancer vaccine that cuts melanoma spread](https://mins.news/en/item/26640) — Al Jazeera, 2026-08-19
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19
- [Merck, Moderna Shares Soar After Melanoma Trial Success](https://mins.news/en/video/26309) — Bloomberg Television, 2026-08-19